eLearning
| eLEARNING SERIES | QLD OPIOID TREATMENT PROGRAM |
|---|---|
| MODULE NAME | Buprenorphine-naloxone and long-acting injection buprenorphine prescriber training |
| MODULE NUMBER | Module 2 |
| LEARNING LEVEL | Level 4 – AOD Treatment Specific |
| TARGET AUDIENCE | Prospective QOTP prescribers (medical and nurse practitioners only) |
| MODULE AIM | This module aims to equip the learner with the knowledge required to safely and effectively prescribe and administer sublingual buprenorphine-naloxone (Suboxone®) and long acting injection buprenorphine (Buvidal® and Sublocade®) for the treatment of opioid dependence. |
| LEARNING OUTCOMES | By the end of this module, learners will be able to:
NB: This is the second module in the QOTP prescriber course which requires successful completion in order to apply for approval as a Level 2 QOTP prescriber in Queensland, whereby you can then apply to prescribe buprenorphine-naloxone and long acting injection buprenorphine formulations to patients. Do not commence this module if you have not already completed the first QOTP module ("Understanding opioid dependence, assessment and treatment") as this module builds upon knowledge and theories contained within this previous course. Further completion of a third module "Buprenorphine-mono and methadone prescriber training" followed by a clinical placement shadowing an existing Level 1 prescriber - is required in order to become a 'Level 1 Full QOTP Prescriber', whereby you can prescribe all opioid dependence treatment medications available in Queensland. |
| LENGTH | 1 hour |
| CPD | This module is accredited until 30 November 2025 for:
CPD endorsement from RACGP and ACRRM will expire on 1st December 2025. Please refer to your Statement of Completion for full details. NB: Insight uploads CPD hours quarterly to ACRRM and RACGP. |
| REFERENCE LIST | The reference list for this module is available upon request |
| SUGGESTED CITATION | Insight: Centre for AOD Training and Workforce Development. QLD Opioid Treatment Program: Buprenorphine-naloxone and long-acting injection buprenorphine prescriber training. Brisbane: Queensland Health; 2025. Available from: https://insight.qld.edu.au/training/elearning |
| COPYRIGHT INFORMATION | This resource is licensed under Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0). This license requires that reusers give credit to the creator. It allows reusers to copy and distribute the material in any medium or format in unadapted form only, even for commercial purposes. |
| LAST UPDATED | August 2025 |
| REVIEW AND FEEDBACK | As part of our commitment to continuous quality improvement our eLearning modules undergo a minor review every 2 years, and a major review every 4 years. All evaluation responses are carefully considered during these reviews. If you have significant or urgent feedback, we encourage you to email us directly at insight@health.qld.gov.au |